Akebia Therapeutics, Inc. (AKBA)
Akebia Therapeutics, Inc. (AKBA) Insider Trading
Directors, officers and holders of more than 10% of AKBA report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 85 transactions on file: 1 with code P, 17 with code S and 32 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | Butler John P. | CEO and President | M Exercise | 350,000 | Not measured | Not measured |
| Aug 6, 2026 | Butler John P. | CEO and President | M Exercise | 350,000 | $0.6300 | $220,500 |
| Jun 29, 2026 | Ostrowski Erik | SVP, CFO, CBO & Treasurer | S Sale | 56,019 | $1.11 | $62,181 |
| Jun 17, 2026 | Wolf Myles | Director | A Award | 35,700 | Not measured | Not measured |
| Jun 17, 2026 | ROGERS MICHAEL W | Director | A Award | 53,600 | Not measured | Not measured |
| Jun 17, 2026 | ZUMWALT LEANNE M | Director | A Award | 53,600 | Not measured | Not measured |
| Jun 17, 2026 | ZUMWALT LEANNE M | Director | A Award | 35,700 | Not measured | Not measured |
| Jun 17, 2026 | FRIESON RON | Director | A Award | 53,600 | Not measured | Not measured |
| Jun 17, 2026 | ADAMS ADRIAN | Director | A Award | 53,600 | Not measured | Not measured |
| Jun 17, 2026 | FRIESON RON | Director | A Award | 35,700 | Not measured | Not measured |
| Jun 17, 2026 | Wolf Myles | Director | A Award | 53,600 | Not measured | Not measured |
| Jun 17, 2026 | ADAMS ADRIAN | Director | A Award | 35,700 | Not measured | Not measured |
| Jun 17, 2026 | Smith Cynthia | Director | A Award | 53,600 | Not measured | Not measured |
| Jun 17, 2026 | ROGERS MICHAEL W | Director | A Award | 35,700 | Not measured | Not measured |
| Jun 17, 2026 | Smith Cynthia | Director | A Award | 35,700 | Not measured | Not measured |
| Apr 1, 2026 | Vickers Philip J. | Director | A Award | 214,400 | Not measured | Not measured |
| Mar 4, 2026 | Butler John P. | CEO and President | P Purchase | 69,270 | $1.25 | $86,588 |
| Feb 2, 2026 | Butler John P. | CEO and President | S Sale | 46,660 | $1.39 | $64,857 |
| Feb 2, 2026 | Burke Steven Keith | SVP, Chief Medical Officer | S Sale | 25,375 | $1.39 | $35,271 |
| Feb 2, 2026 | Burke Steven Keith | SVP, Chief Medical Officer | S Sale | 21,582 | $1.39 | $29,999 |
| Feb 2, 2026 | Grund Nicholas | Chief Commercial Officer | S Sale | 31,244 | $1.39 | $43,429 |
| Feb 2, 2026 | Grund Nicholas | Chief Commercial Officer | S Sale | 53,585 | $1.39 | $74,483 |
| Feb 2, 2026 | Malabre Richard C | SVP, Chief Accounting Officer | S Sale | 36,142 | $1.39 | $50,237 |
| Feb 2, 2026 | Malabre Richard C | SVP, Chief Accounting Officer | S Sale | 13,382 | $1.39 | $18,601 |
| Feb 2, 2026 | Rucci Carolyn M. | SVP, Chief Legal Officer | S Sale | 16,846 | $1.39 | $23,416 |
| Feb 2, 2026 | Rucci Carolyn M. | SVP, Chief Legal Officer | S Sale | 25,382 | $1.39 | $35,281 |
| Feb 2, 2026 | Rucci Carolyn M. | SVP, Chief Legal Officer | S Sale | 27,544 | $1.39 | $38,286 |
| Feb 2, 2026 | Ostrowski Erik | SVP, CFO, CBO & Treasurer | S Sale | 34,951 | $1.39 | $48,582 |
| Feb 2, 2026 | Butler John P. | CEO and President | S Sale | 83,689 | $1.39 | $116,328 |
| Feb 2, 2026 | Butler John P. | CEO and President | A Award | 175,250 | $1.41 | $247,103 |
| Feb 2, 2026 | Butler John P. | CEO and President | S Sale | 114,891 | $1.39 | $159,698 |
| Feb 2, 2026 | Butler John P. | CEO and President | S Sale | 96,065 | $1.39 | $133,530 |
| Feb 2, 2026 | Burke Steven Keith | SVP, Chief Medical Officer | S Sale | 20,701 | $1.39 | $28,774 |
| Jan 30, 2026 | Butler John P. | CEO and President | A Award | 1,115,000 | Not measured | Not measured |
| Jan 30, 2026 | Grund Nicholas | Chief Commercial Officer | A Award | 204,000 | Not measured | Not measured |
| Jan 30, 2026 | Burke Steven Keith | SVP, Chief Medical Officer | A Award | 204,000 | Not measured | Not measured |
| Jan 30, 2026 | Ostrowski Erik | SVP, CFO, CBO & Treasurer | A Award | 204,000 | Not measured | Not measured |
| Jan 30, 2026 | Malabre Richard C | SVP, Chief Accounting Officer | A Award | 79,000 | Not measured | Not measured |
| Jan 30, 2026 | Rucci Carolyn M. | SVP, Chief Legal Officer | A Award | 190,000 | Not measured | Not measured |
| Jan 30, 2026 | Butler John P. | CEO and President | A Award | 743,000 | Not measured | Not measured |
| Jan 30, 2026 | Grund Nicholas | Chief Commercial Officer | A Award | 320,000 | Not measured | Not measured |
| Jan 30, 2026 | Burke Steven Keith | SVP, Chief Medical Officer | A Award | 320,000 | Not measured | Not measured |
| Jan 30, 2026 | Ostrowski Erik | SVP, CFO, CBO & Treasurer | A Award | 320,000 | Not measured | Not measured |
| Jan 30, 2026 | Malabre Richard C | SVP, Chief Accounting Officer | A Award | 119,000 | Not measured | Not measured |
| Jan 30, 2026 | Rucci Carolyn M. | SVP, Chief Legal Officer | A Award | 270,000 | Not measured | Not measured |
| Jun 30, 2025 | Ostrowski Erik | SVP, CFO, CBO & Treasurer | S Sale | 41,314 | $3.67 | $151,622 |
| Jun 10, 2025 | ROGERS MICHAEL W | Director | A Award | 53,600 | Not measured | Not measured |
| Jun 10, 2025 | GILMAN STEVEN C | Director | A Award | 53,600 | Not measured | Not measured |
| Jun 10, 2025 | FRIESON RON | Director | A Award | 53,600 | Not measured | Not measured |
| Jun 10, 2025 | FRIESON RON | Director | A Award | 35,700 | Not measured | Not measured |
The full Form 4 history is on the AKBA company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.